Celldex Therapeutics
CLDX
#4748
Rank
HK$15.92 B
Marketcap
HK$239.69
Share price
-0.58%
Change (1 day)
49.47%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -HK$2 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are HK$2.6 Million. In 2024 the company made an earning of -HK$1.53 Billion a decrease over its 2023 earnings that were of -HK$1.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$2 Billion30.87%
2024 -HK$1.53 Billion37.34%
2023 -HK$1.12 Billion32.63%
2022 -HK$0.84 Billion54.88%
2021 -HK$0.55 Billion39.49%
2020 -HK$0.39 Billion-9.08%
2019 -HK$0.43 Billion-28.64%
2018 -HK$0.6 Billion-30.11%
2017 -HK$0.86 Billion-17.75%
2016 -HK$1.04 Billion4.5%
2015 -HK$1 Billion4.09%
2014 -HK$0.96 Billion51.57%
2013 -HK$0.64 Billion40.1%
2012 -HK$0.46 Billion
2010 -HK$9.76 Million-96.59%
2009 -HK$0.29 Billion
2006 -HK$0.18 Billion
2004 -HK$0.11 Billion15.75%
2003 -HK$91.8 Million-18.69%
2002 -HK$0.12 Billion-41.22%
2001 -HK$0.2 Billion59%
2000 -HK$0.13 Billion27.65%
1999 -HK$94.63 Million53.12%
1998 -HK$61.81 Million2.6%
1997 -HK$60.24 Million-33.62%
1996 -HK$90.75 Million-1.69%
1995 -HK$92.31 Million22.92%
1994 -HK$75.1 Million-0%
1993 -HK$75.1 Million
1991 -HK$46.16 Million90.32%
1990 -HK$24.26 Million10.71%
1989 -HK$21.91 Million833.33%
1988 -HK$2.35 Million-400%
1987 HK$0.78 M-125%
1986 -HK$3.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.71 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.49 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$72.93 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-HK$21.95 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-HK$6.19 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.16 B-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.29 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA